Detailed price information for Boston Scientific Corp (BSX-N) from The Globe and Mail including charting and trades.

Boston Scientific enters agreement to acquire Penumbra for $14.5 billion: Marlborough, Massachusetts Friday, January 16, 2026, 14:30 Hrs [IST] Boston Scientific Corporation and Pe ...

Boston will inherit products, including Penumbra’s Lightning thrombectomy systems, to advance its vascular care provision.

Boston Scientific has agreed to acquire Penumbra in a deal worth about $14.5 billion. Boston Scientific has agreed to acquire ...

With the planned purchase, Boston Scientific will gain several thrombectomy devices to remove clots from blood vessels.

Penumbra shares soared 12% to $351.46 on Thursday. Boston Scientific stock slumped 4.1%, making it one of the worst ...

Boston Scientific’s $374/share Penumbra deal boosts mechanical thrombectomy exposure and growth. Click here to learn more ...

Boston Scientific Corp (NYSE:BSX) announced on Thursday that it has agreed to acquire medical technology company Penumbra ...

Boston Scientific Corp (NYSE:BSX) said on Thursday it has reached a deal to acquire medical technology firm Penumbra ...

Boston Scientific Corporation and Penumbra, Inc. announced that the companies have entered into a definitive agreement under ...

In a significant move within the medtech industry, Boston Scientific announced on Thursday its intention to acquire Penumbra for approximately $14.5 billion. This acquisition aims to enhance Boston ...

Acquisition to expand Boston Scientific's cardiovascular portfolio and further address increasing prevalence of vascular diseases Provides scaled entry into mechanical ...